Skip to main content
Top
Published in: Current Cardiovascular Imaging Reports 1/2014

Open Access 01-01-2014 | Heart Failure and Targeted Imaging (T Schindler and E Schelbert, Section Editors)

Imaging of Myocardial Oxidative Metabolism in Heart Failure

Authors: Masanao Naya, Nagara Tamaki

Published in: Current Cardiovascular Imaging Reports | Issue 1/2014

Login to get access

Abstract

Metabolic imaging has a potential for better understanding of pathophysiology of heart failure. C-11 acetate is taken up by the heart, rapidly converted to acetylCoA and readily metabolized to C-11 CO2 through TCA cycle with oxidative phosphorylation. Thus, the myocardial turnover rate of this tracer is tightly correlated with its clearance of C-11 CO2, reflecting overall oxidative metabolism. The heart relies on aerobic oxidative substrate for the generation of ATP, which is required to maintain its contractile function. The progression to heart failure is associated with a gradual decline in the activity of mitochondrial respiratory pathways, leading to diminished capacity for ATP production. The work metabolic index can also be estimated by the combination of C-11 acetate PET and hemodynamics by echocardiography, the metabolic index is a significant marker to understand the pathophysiology of heart failure as well as myocardial oxidative metabolism.
Literature
1.
go back to reference Pike VW et al. Preparation of [1–11C]acetate–an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot. 1982;33(7):505–12.PubMedCrossRef Pike VW et al. Preparation of [1–11C]acetate–an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot. 1982;33(7):505–12.PubMedCrossRef
2.
go back to reference Brown M et al. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation. 1987;76(3):687–96.PubMedCrossRef Brown M et al. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation. 1987;76(3):687–96.PubMedCrossRef
3.
go back to reference Buxton DB et al. Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ Res. 1988;63(3):628–34.PubMedCrossRef Buxton DB et al. Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ Res. 1988;63(3):628–34.PubMedCrossRef
4.
go back to reference Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med. 1989;30(2):187–93.PubMed Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med. 1989;30(2):187–93.PubMed
5.
go back to reference Tamaki N et al. Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states. Ann Nucl Med. 1992;6(4):221–8.PubMedCrossRef Tamaki N et al. Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states. Ann Nucl Med. 1992;6(4):221–8.PubMedCrossRef
6.
go back to reference Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation. 1990;81(5):1594–605.PubMedCrossRef Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation. 1990;81(5):1594–605.PubMedCrossRef
7.
go back to reference Buxton DB et al. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Circulation. 1989;79(1):134–42.PubMedCrossRef Buxton DB et al. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Circulation. 1989;79(1):134–42.PubMedCrossRef
8.
go back to reference Buxton DB et al. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium. Circulation. 1992;85(5):1842–56.PubMedCrossRef Buxton DB et al. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium. Circulation. 1992;85(5):1842–56.PubMedCrossRef
9.
go back to reference Hashimoto T et al. Responses of blood flow, oxygen consumption, and contractile function to inotropic stimulation in stunned canine myocardium. Am Heart J. 1994;127(5):1250–62.PubMedCrossRef Hashimoto T et al. Responses of blood flow, oxygen consumption, and contractile function to inotropic stimulation in stunned canine myocardium. Am Heart J. 1994;127(5):1250–62.PubMedCrossRef
10.
go back to reference Heyndrickx GR et al. Recovery of regional contractile function and oxidative metabolism in stunned myocardium induced by 1-hour circumflex coronary artery stenosis in chronically instrumented dogs. Circ Res. 1993;72(4):901–13.PubMedCrossRef Heyndrickx GR et al. Recovery of regional contractile function and oxidative metabolism in stunned myocardium induced by 1-hour circumflex coronary artery stenosis in chronically instrumented dogs. Circ Res. 1993;72(4):901–13.PubMedCrossRef
11.
go back to reference Beanlands RS et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol. 1993;22(5):1389–98.PubMedCrossRef Beanlands RS et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol. 1993;22(5):1389–98.PubMedCrossRef
12.
go back to reference Beanlands RS et al. The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy. J Nucl Cardiol. 1994;1(1):3–16.PubMedCrossRef Beanlands RS et al. The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy. J Nucl Cardiol. 1994;1(1):3–16.PubMedCrossRef
13.
go back to reference Bengel FM et al. Myocardial efficiency and sympathetic reinnervation after orthotopic heart transplantation: a noninvasive study with positron emission tomography. Circulation. 2001;103(14):1881–6.PubMedCrossRef Bengel FM et al. Myocardial efficiency and sympathetic reinnervation after orthotopic heart transplantation: a noninvasive study with positron emission tomography. Circulation. 2001;103(14):1881–6.PubMedCrossRef
14.
go back to reference Walsh MN et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med. 1989;30(11):1798–808.PubMed Walsh MN et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med. 1989;30(11):1798–808.PubMed
15.
go back to reference Henes CG et al. The Time Course of Restoration of Nutritive Perfusion, Myocardial Oxygen-Consumption, and Regional Function after Coronary Thrombolysis. Coronary Artery Disease. 1990;1(6):687–96.CrossRef Henes CG et al. The Time Course of Restoration of Nutritive Perfusion, Myocardial Oxygen-Consumption, and Regional Function after Coronary Thrombolysis. Coronary Artery Disease. 1990;1(6):687–96.CrossRef
16.
go back to reference Kalff V et al. Use of C-11 Acetate and Dynamic Positron Emission Tomography to Assess Regional Myocardial Oxygen-Consumption in Patients with Acute Myocardial-Infarction Receiving Thrombolysis or Coronary Angioplasty. American Journal of Cardiology. 1993;71(7):529–35.PubMedCrossRef Kalff V et al. Use of C-11 Acetate and Dynamic Positron Emission Tomography to Assess Regional Myocardial Oxygen-Consumption in Patients with Acute Myocardial-Infarction Receiving Thrombolysis or Coronary Angioplasty. American Journal of Cardiology. 1993;71(7):529–35.PubMedCrossRef
17.
go back to reference Czernin J et al. Regional Blood-Flow, Oxidative-Metabolism, and Glucose-Utilization in Patients with Recent Myocardial-Infarction. Circulation. 1993;88(3):884–95.PubMedCrossRef Czernin J et al. Regional Blood-Flow, Oxidative-Metabolism, and Glucose-Utilization in Patients with Recent Myocardial-Infarction. Circulation. 1993;88(3):884–95.PubMedCrossRef
18.
go back to reference Vanoverschelde JL et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium Circulation. 1993;87(5):1513–23. Vanoverschelde JL et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium Circulation. 1993;87(5):1513–23.
19.
go back to reference Gropler RJ et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol. 1992;19(5):989–97.PubMedCrossRef Gropler RJ et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol. 1992;19(5):989–97.PubMedCrossRef
20.
go back to reference Gropler RJ et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol. 1992;20(3):569–77.PubMedCrossRef Gropler RJ et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol. 1992;20(3):569–77.PubMedCrossRef
21.
go back to reference Weinheimer CJ et al. Functional recovery after reperfusion is predicated on recovery of myocardial oxidative metabolism. Am Heart J. 1993;125(4):939–49.PubMedCrossRef Weinheimer CJ et al. Functional recovery after reperfusion is predicated on recovery of myocardial oxidative metabolism. Am Heart J. 1993;125(4):939–49.PubMedCrossRef
22.
go back to reference Hicks RJ et al. Metabolic imaging by positron emission tomography early after myocardial infarction as a predictor of recovery of myocardial function after reperfusion. J Nucl Cardiol. 1994;1(2 Pt 1):124–37.PubMedCrossRef Hicks RJ et al. Metabolic imaging by positron emission tomography early after myocardial infarction as a predictor of recovery of myocardial function after reperfusion. J Nucl Cardiol. 1994;1(2 Pt 1):124–37.PubMedCrossRef
23.
go back to reference Chan SY et al. Use of the Metabolic Tracer Carbon-11-Acetate for Evaluation of Regional Myocardial Perfusion. Journal of Nuclear Medicine. 1991;32(4):665–72.PubMed Chan SY et al. Use of the Metabolic Tracer Carbon-11-Acetate for Evaluation of Regional Myocardial Perfusion. Journal of Nuclear Medicine. 1991;32(4):665–72.PubMed
24.
go back to reference Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med. 1991;32(2):245–51.PubMed Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med. 1991;32(2):245–51.PubMed
25.
go back to reference Wolpers HG et al. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction Circulation. 1997;95(6):1417–24. Wolpers HG et al. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction Circulation. 1997;95(6):1417–24.
26.
go back to reference Gropler RJ et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol. 1993;22(6):1587–97.PubMedCrossRef Gropler RJ et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol. 1993;22(6):1587–97.PubMedCrossRef
27.
go back to reference Rubin PJ et al. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. American Journal of Cardiology. 1996;78(11):1230–5.PubMedCrossRef Rubin PJ et al. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. American Journal of Cardiology. 1996;78(11):1230–5.PubMedCrossRef
28.
go back to reference Vanoverschelde JL et al. Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake Circulation. 1992;85(1):9–21. Vanoverschelde JL et al. Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake Circulation. 1992;85(1):9–21.
29.
go back to reference Henes CG et al. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med. 1989;30(9):1489–99.PubMed Henes CG et al. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med. 1989;30(9):1489–99.PubMed
30.
go back to reference Hata T et al. Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion Circulation. 1996;94(8):1834–41. Hata T et al. Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion Circulation. 1996;94(8):1834–41.
31.
go back to reference Yoshinaga K et al. Reduced oxidative metabolic response in dysfunctional myocardium with preserved glucose metabolism but with impaired contractile reserve. J Nucl Med. 2004;45(11):1885–91.PubMed Yoshinaga K et al. Reduced oxidative metabolic response in dysfunctional myocardium with preserved glucose metabolism but with impaired contractile reserve. J Nucl Med. 2004;45(11):1885–91.PubMed
32.
go back to reference Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest. 2005;115(3):547–55.PubMedCentralPubMed Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest. 2005;115(3):547–55.PubMedCentralPubMed
33.
go back to reference Tadamura E et al. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med. 1996;37(4):572–7.PubMed Tadamura E et al. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med. 1996;37(4):572–7.PubMed
34.
go back to reference Bach DS et al. Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 1995;25(6):1258–62.PubMedCrossRef Bach DS et al. Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 1995;25(6):1258–62.PubMedCrossRef
35.
go back to reference Wu YW et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J. 2008;72(5):786–92.PubMedCrossRef Wu YW et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J. 2008;72(5):786–92.PubMedCrossRef
36.
go back to reference Hicks RJ et al. Assessment of myocardial oxidative metabolism in aortic valve disease using positron emission tomography with C-11 acetate. Am Heart J. 1992;123(3):653–64.PubMedCrossRef Hicks RJ et al. Assessment of myocardial oxidative metabolism in aortic valve disease using positron emission tomography with C-11 acetate. Am Heart J. 1992;123(3):653–64.PubMedCrossRef
37.••
go back to reference Naya M et al. Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis: assessment using 11C-acetate positron emission tomography. Eur J Nucl Med Mol Imaging. 2010;37(12):2242–8. This paper shows an increase in oxidative metabolism in patients with aortic stenosis with its reduction after operation, indicating such an increase in oxidative metabolism in AS largely attributable to the LV pressire overload. (The most important recent report from our group.).PubMedCrossRef Naya M et al. Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis: assessment using 11C-acetate positron emission tomography. Eur J Nucl Med Mol Imaging. 2010;37(12):2242–8. This paper shows an increase in oxidative metabolism in patients with aortic stenosis with its reduction after operation, indicating such an increase in oxidative metabolism in AS largely attributable to the LV pressire overload. (The most important recent report from our group.).PubMedCrossRef
38.
go back to reference Bing RJ, Hammond MM, et al. The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man. Am Heart J. 1949;38(1):1–24.PubMedCrossRef Bing RJ, Hammond MM, et al. The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man. Am Heart J. 1949;38(1):1–24.PubMedCrossRef
39.
go back to reference Stolen KQ et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2003;41(3):460–7.PubMedCrossRef Stolen KQ et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2003;41(3):460–7.PubMedCrossRef
40.
go back to reference Christenson SD et al. Effects of simultaneous and optimized sequential cardiac resynchronization therapy on myocardial oxidative metabolism and efficiency. J Cardiovasc Electrophysiol. 2008;19(2):125–32.PubMedCrossRef Christenson SD et al. Effects of simultaneous and optimized sequential cardiac resynchronization therapy on myocardial oxidative metabolism and efficiency. J Cardiovasc Electrophysiol. 2008;19(2):125–32.PubMedCrossRef
41.
go back to reference Ukkonen H et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation. 2003;107(1):28–31.PubMedCrossRef Ukkonen H et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation. 2003;107(1):28–31.PubMedCrossRef
42.
go back to reference Matsui Y et al. Integrated overlapping ventriculoplasty combined with papillary muscle plication for severely dilated heart failure. J Thorac Cardiovasc Surg. 2004;127(4):1221–3.PubMedCrossRef Matsui Y et al. Integrated overlapping ventriculoplasty combined with papillary muscle plication for severely dilated heart failure. J Thorac Cardiovasc Surg. 2004;127(4):1221–3.PubMedCrossRef
43.••
go back to reference Sugiki T et al. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy. JACC Cardiovasc Imaging. 2011;4(7):762–70. This paper nicely shows an imporvement of cardiac efficiency in association with reduced LV volume after surgical ventricular reconstruction and mitral complex reconstruction in patients with severe heart failure. This paper is also received an editorial comments from Dr Robert Bonow. (The most important recent report from our group.).PubMedCrossRef Sugiki T et al. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy. JACC Cardiovasc Imaging. 2011;4(7):762–70. This paper nicely shows an imporvement of cardiac efficiency in association with reduced LV volume after surgical ventricular reconstruction and mitral complex reconstruction in patients with severe heart failure. This paper is also received an editorial comments from Dr Robert Bonow. (The most important recent report from our group.).PubMedCrossRef
44.
go back to reference Chow BJ et al. Effects of mitral valve surgery on myocardial energetics in patients with severe mitral regurgitation. Circ Cardiovasc Imaging. 2010;3(3):308–13.PubMedCrossRef Chow BJ et al. Effects of mitral valve surgery on myocardial energetics in patients with severe mitral regurgitation. Circ Cardiovasc Imaging. 2010;3(3):308–13.PubMedCrossRef
45.
go back to reference Hicks RJ et al. Assessment of right ventricular oxidative metabolism by positron emission tomography with C-11 acetate in aortic valve disease. Am J Cardiol. 1991;67(8):753–7.PubMedCrossRef Hicks RJ et al. Assessment of right ventricular oxidative metabolism by positron emission tomography with C-11 acetate in aortic valve disease. Am J Cardiol. 1991;67(8):753–7.PubMedCrossRef
46.•
go back to reference Wong YY et al. 11C-Acetate clearance as an index of oxygen consumption of the right myocardium in idiopathic pulmonary arterial hypertension: a validation study using 15O-labeled tracers and PET. J Nucl Med. 2013;54(8):1258–62. This is the first report to analyze oxidative metabolism in the right ventricle using PET in patients with idiopathic pulmonary hypertension. (The important recent report from another group.).PubMedCrossRef Wong YY et al. 11C-Acetate clearance as an index of oxygen consumption of the right myocardium in idiopathic pulmonary arterial hypertension: a validation study using 15O-labeled tracers and PET. J Nucl Med. 2013;54(8):1258–62. This is the first report to analyze oxidative metabolism in the right ventricle using PET in patients with idiopathic pulmonary hypertension. (The important recent report from another group.).PubMedCrossRef
Metadata
Title
Imaging of Myocardial Oxidative Metabolism in Heart Failure
Authors
Masanao Naya
Nagara Tamaki
Publication date
01-01-2014
Publisher
Springer US
Published in
Current Cardiovascular Imaging Reports / Issue 1/2014
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-013-9244-y

Other articles of this Issue 1/2014

Current Cardiovascular Imaging Reports 1/2014 Go to the issue

Heart Failure and Targeted Imaging (T Schindler and E Schelbert, Section Editors)

Imaging of Cardiac Autonomic Innervation with SPECT and PET

Heart Failure and Targeted Imaging (T. Schindler and E. Schelbert, Section Editors)

Recent Developments in Imaging of Myocardial Angiotensin Receptors

Heart Failure and Targeted Imaging (T. Schindler and E. Schelbert, Section Editors)

What You See is What You Get? Imaging of Cell Therapy for Cardiac Regeneration